P M Mattingly

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The incidence of amrinone-induced thrombocytopenia has been reported to be 2.4 percent in patients receiving intravenous therapy. To date there have been no reports of bleeding in these patients nor have there been reports of other hematologic abnormalities secondary to amrinone administration. This case report describes a patient whose hematologic values(More)
  • 1